Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis

Table 4 Results of Cox multivariate regression 5-year survival rate of the LUSC patients

Clinical features	B	SE	Wald	P	HR	95.0%CI for HR
Differentiation	0.616	0.343	3.219	0.073	1.851	0.945–3.626
pT classification	0.274	0.250	1.195	0.274	1.315	0.805–2.147
pN	1.669	0.650	6.588	0.010	5.309	1.484–18.997
pTNM stage	0.254	0.403	0.397	0.528	1.289	0.585–2.840
YTHDF2expression	0.781	0.355	4.856	0.028	2.184	1.090–4.377

B, regression coefficient; SE, standard error; Wald, Wald value; HR, hazard ratio; CI, confidence interval; pT classification, tumor size; pN, lymph node metastasis and pTNM stage, tumor stage

ISSN: 1475-2867